Key Considerations for Labeling Cell and Gene Therapies

This white paper outlines the key considerations for labeling cell and gene therapies, particularly in the context of clinical trials. It emphasizes the challenges associated with ensuring the safe delivery of drug products, especially those requiring cryogenic temperatures. The paper details the importance of effective labeling strategies to maintain the integrity of therapies during transport and storage. It discusses factors such as container type, label application procedures, desired label types, and regulatory requirements that vary by country. The paper also highlights the need for flexibility in labeling to accommodate changes in clinical trial protocols and patient-specific information. It stresses the significance of working with qualified labeling partners to develop comprehensive labeling plans that address the unique needs of cell and gene therapies. Additionally, the document notes the importance of conducting label validation studies to ensure label performance over time, thereby preventing costly recalls and ensuring compliance with clinical trial requirements.